Lexicon Pharmaceuticals
LXRX
LXRX
106 hedge funds and large institutions have $417M invested in Lexicon Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 25 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11.09% less ownership
Funds ownership: 97.33% → 86.24% (-11%)
19% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 31
Holders
106
Holding in Top 10
2
Calls
$2.26M
Puts
$1.48M
Top Buyers
| 1 | +$37.5M | |
| 2 | +$37.4M | |
| 3 | +$5.15M | |
| 4 |
D.E. Shaw & Co
New York
|
+$2.83M |
| 5 |
Millennium Management
New York
|
+$2.73M |
Top Sellers
| 1 | -$5.75M | |
| 2 | -$3.62M | |
| 3 | -$3.38M | |
| 4 |
BlackRock
New York
|
-$3.31M |
| 5 |
Lazard Asset Management
New York
|
-$2.52M |